FIDO Study: 10-Year Outcomes of Eyes Receiving Continuous, Fixed-Interval Dosing of Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration

  • Ivan J. Suner, MD, MBA
  • Video
  • Published 2019

Ivan J. Suner, MD, MBA

AMD Neovascular Part II Symposium


See more